MOUNTAIN VIEW, CA — PlaceWare Inc., the leader in
Web conferencing services for Internet-based business communications and
collaboration, today announced it has raised more than $30 million in an over
subscribed private placement financing. The funding will enable PlaceWare to
widen its leadership in the market with its scalable and reliable web services
platform. The lead investor was 3i, a leading international venture capital
company with co-lead by GIC, the government of Singapore. These new investors
will help PlaceWare continue its global expansion into Europe, Middle East,
Africa and Asia-Pacific. J. Sanford (Sandy) Miller, a managing director at
3i, was appointed to the board of directors, increasing the number of
directors to eight.
HAYWARD, CA — Calyx Therapeutics Inc., a pharmaceutical company focusing on oral therapies for diabetes and inflammatory diseases, today announced that it has completed a $30 million round of funding. The company, which bases its research on natural plant extracts with well-documented medical benefits for humans, is able to significantly cut the time and investment necessary to take promising drug leads into human trials. Calyx has raised a total of $44.1 million in four rounds of financing since its founding in 1997.
The $30 million round was co-led by BA Venture Partners (the venture capital affiliate of Bank of America) and Walden International (a group of international venture capital funds in the U.S. and the Asia Pacific region). Additional investments came from A.M. Pappas & Associates, as well as previous investors U.S. Venture Partners, ABS Ventures and Morgenthaler.
BOSTON — GenuOne Inc., a leading provider of comprehensive brand security systems, today announced it has raised $7 million in Series C financing. This round is led by the publicly listed, South African-based venture capital group, VenFin, Ltd., and also includes funding from Boston-based Integrity Partners, LLP, as well as several prominent Massachusetts businessmen, including former Boston Bruin Cam Neely.
VenFin served as the primary investor in Certus International, a leading developer of patent-pending on-line authentication products, which was acquired by GenuOne earlier this month.
WOBURN, MA — Swift Rivers Inc., a leading returns management solutions provider, today announced it received $3.6 Million in its’ second round of financing led by Zero Stage Capital.
Swift Rivers offers supply chain solutions that optimize product returns, both within companies and across the whole reverse supply chain network. Swift Rivers solutions deliver significant value by: increasing the velocity of the product returns process; accelerating cash to cash cycles; improving returns process controls; and delivering bottom-line results. Proceeds of the funding will be used for working capital purposes to fuel market growth, alliance development, and ongoing development of a series of optimization solution modules.
CONSHOHOCKEN, PA — TenX Capital Partners today announced that Ross Gatlin has joined its team as managing director focusing on development and assessment of acquisition opportunities. This staffing addition follows the firm’s recent announcement of its entry into the middle- market acquisition business.
Mr. Gatlin, who was a founding principal of Carlye Management Group, will draw on his extensive experience in corporate finance and business management to support the firm’s goal of achieving three to four acquisitions in the next year.
OLD GREENWICH, CT — SoundView Technology Group Inc. (Nasdaq: SNDV), a technology focused investment banking firm, today reported that it has repurchased 6.066 million of its Class B common shares from The Goldman Sachs Group and that General Atlantic Partners, a global private equity investment firm and a strategic investor in SoundView, also purchased 4.5 million SoundView Class B common shares in the privately negotiated transaction. The balance of the 11,666,666 Class B common shares held by Goldman Sachs was placed with an institutional investor. The transaction was priced at $1.71 per share. Goldman Sachs continues to hold warrants to purchase 5.6 million Class B shares of SoundView Technology Group common stock that expire in April 2004 and have an exercise price of $5.57.
NEW YORK — Select Media Communications, Inc. (OTCBB:SMTV), today announced the completion of a Private Equity Line of Credit Agreement with Greenville Financial Ltd. providing for up to $20 million in capital to the Company.
Monthly draw down amounts utilizing this Private Equity Line of Credit Agreement are at the discretion of Select Media’s management. The Company has agreed to file a registration statement covering shares, which may be issued pursuant to the Private Equity Line, and to cover 75,000 warrants which have been granted to Greenville Financial in association with the equity credit facility. The warrants were priced at 110% of the closing bid price on the trading day immediately preceding execution of the Agreement.
WILMINGTON, MA — Charles River Laboratories International Inc. (CRL:NYSE) announced today that the lead investor group in its September 1999 management-led leveraged buy-out transaction, Credit Suisse First Boston’s DLJ Merchant Banking Group (DLJMB), has distributed to the limited partners in its private equity funds approximately 1.9 million shares of Charles River’s common stock. On November 8, 2001, DLJMB also distributed 1.9 million CRL shares to these investors. Prior to today’s distribution, DLJMB’s private equity funds held approximately 15% of Charles River’s outstanding common shares. Following this distribution, the DLJMB funds will hold approximately 4.7 million shares or 11% of the Company’s outstanding common stock.
OTTAWA –World Heart Corp. (NASDAQ: WHRT, TSE: WHT) announces that it has agreed to sell, on a private placement basis, 3,027,000 special warrants (“Special Warrants”) at a price of Cdn $5.50 per Special Warrant for gross proceeds of $16,648,500. Each Special Warrant is exercisable, without additional consideration, for one Unit, with each Unit representing one common share of the Corporation and one warrant to purchase a common share. Each warrant will be exercisable into one common share at an exercise price of Cdn $6.01 per share for a period of two years. The Corporation also announced that in a separate transaction, a labour sponsored venture capital corporation will purchase, at a price of Cdn $5.50 per share, shares of a new research and development corporation which will use the gross proceeds of $3,503,500 to fund clinical trials and product development expenses related to WorldHeart’s ongoing activities. These shares will be exchangeable for an equivalent number of Units. The total gross proceeds from both transactions, which are expected to close on, or about, December 17, 2001, are $20,152,000. The underwriters have been granted an option to purchase up to an additional 910,000 Special Warrants exercisable until December 21, 2001 on the same terms on behalf of a single Health Care Fund.
For yesterday’s Wire, click here
|This is a free sample of content available to paid subscribers of Private Equity Week.
Click here for more information.